FDA
-
-
-
-
-
-
-
William Blair on Kyverna Therapeutics Inc (KYTX): AAN updates 'extremely positive,' data supports BLA
-
-
-
-
-
-
-
Kyverna to present stiff person syndrome trial data at AAN 2026
-
-
-
-
-
-
-
Kyverna reports positive phase 2 results for myasthenia gravis treatment
-
-
-
-
-
-
-
Kyverna Therapeutics Highlights Neuroimmunology CAR T Franchise and Registrational Phase 3 Trial Design in Myasthenia Gravis at Virtual KOL Event
-
-
-
-
-
-
-
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
-
323,580 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

